Abbott’s neuromodulation systems can significantly reduce pain-related healthcare visits for people living with chronic pain, according to five-year data.

Abbott Park, Illinois Tuesday, January 27, 2026, 13:00 Hrs [IST] ...

The MarketWatch News Department was not involved in the creation of this content. Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use ...

Real-time insights reveal BIOTRONIK Neuro's remote monitoring with remote programming led to high rates of therapy use and lower explant rates LAKE OSWEGO, Ore., Jan. 5, 2026 /PRNewswire/ -- A new ...

Abbott Laboratories ( ABT) Q4 2025 Earnings Call January 22, 2026 9:00 AM EST Good morning, and thank you for standing by.

Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings Call Transcript January 22, 2026 Abbott Laboratories reports earnings inline ...

Sean Forsberg was the first Canadian to get a closed-loop spinal cord stimulator. Mariko Taylor from manufacturer Medtronic poses beside him. Photo submitted. As the local anesthetic faded after ...

TAMPA, Fla., Jan. 13, 2026 /PRNewswire/ -- PainTEQ, a medical device company dedicated to advancing minimally invasive solutions for sacroiliac (SI) joint dysfunction, today announced the appointment ...

Abbott Laboratories ABT is slated to report fourth-quarter 2025 results on Jan. 22, before the opening bell. The company ...

Background Spinal cord stimulation (SCS) has become a cornerstone of neuromodulatory interventions for chronic pain, offering ...

On December 22, Abbott Laboratories (NYSE:ABT) said the US Food and Drug Administration has approved the company’s Volt™ PFA System to treat patients with atrial fibrillation, or AFib. The company ...

Abbott Laboratories (NYSE:ABT) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. Courtesy of Abbott Labs On December 22, Abbott Laboratories (NYSE:ABT) said the US Food and Drug ...